Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis

被引:0
|
作者
Cascino, I
Papoff, G
DeMaria, R
Testi, R
Ruberti, G
机构
[1] CNR,INST CELL BIOL,DEPT IMMUNOBIOL,I-00137 ROME,ITALY
[2] UNIV ROMA TOR VERGATA,DEPT EXPTL MED & BIOCHEM SCI,I-00173 ROME,ITALY
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 156卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas/Apo-1 (CD95) is an apoptosis-signaling cell surface receptor belonging to the TNF receptor family. Tumor cells resistant to Fas-mediated apoptosis have been described, but to date, the mechanisms responsible for this resistance are not well understood. We found that a series of apoptosis-resistant clones from human HUT78 lymphoma cells express a splicing variant coding for a truncated Fas molecule that lacks the intracellular death-signaling domain. The mutation responsible for the FasExo8Del expression was identified as a deletion-insertion in the intron 7/exon 8 region of the Fas gene. Moreover this mutation affects the phenotype in a dominant negative fashion, i.e., even in the presence of the normal receptor.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [1] Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
    Peter, ME
    Krammer, PH
    CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 545 - 551
  • [2] CD95(APO-1/FAS)-mediated apoptosis: Signals, chemotherapy and tumor rejection
    Krammer, PH
    JOURNAL OF PATHOLOGY, 1999, 187 : 17A - 17A
  • [3] Drug-induced CD95 (APO-1/FAS)-mediated apoptosis
    Krammer, PH
    ANNALS OF ONCOLOGY, 1998, 9 : 13 - 13
  • [4] Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes
    Hornung, F
    Zheng, LX
    Lenardo, MJ
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 3816 - 3822
  • [5] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06): : 1675 - 1687
  • [6] Regulation of apoptosis through CD95 (APO-1/FAS) receptor/ligand
    Debatin, KM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 228 - 228
  • [7] Fas/Apo-1 (CD95)-mediated and CD95-independent apoptosis of malignant plasma cells
    Hata, H
    Matsuzaki, H
    Takeya, M
    Takatsuki, K
    LEUKEMIA & LYMPHOMA, 1996, 24 (1-2) : 35 - &
  • [8] CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells
    Stahnke, K
    Hecker, S
    Kohne, E
    Debatin, KM
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (09) : 844 - 850
  • [9] Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    Collins, JK
    Shanahan, F
    DISEASES OF THE ESOPHAGUS, 1999, 12 (02): : 83 - 89
  • [10] Sensitivity and resistance to apoptosis in the APO-1 (Fas/CD95) system
    Debatin, KM
    ONKOLOGIE, 1996, 19 : 3 - 5